Your session is about to expire
← Back to Search
Opioid Destruction Education for Postoperative Care
N/A
Waitlist Available
Led By Kristin R Daniel, PharmD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six to eight weeks post discharge
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how patients use opioid destruction bags after surgery for hip or knee replacement. Patients must be 19+ and prescribed an opioid at discharge. Two groups: one gets standard care, one gets special handout and education on safe storage. 6-8 weeks post-surgery, patients are contacted via phone or email for survey.
Who is the study for?
This trial is for adults who've had a total knee or hip replacement, are going home with an opioid prescription, and haven't used opioids before the surgery. It's not for those under 19 or anyone not prescribed opioids after discharge.
What is being tested?
The study focuses on teaching patients about proper storage and destruction of opioid medications post-surgery. Participants will be followed up within 6-8 weeks to discuss their use, storage, and disposal of these pain meds.
What are the potential side effects?
Since this trial involves education rather than medication administration, there are no direct side effects from interventions being studied.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ six to eight weeks post discharge
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six to eight weeks post discharge
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Opioid destruction
Secondary study objectives
Alternative opioid destruction methods
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention group will receive a specialized handout and patient education on the safe storage of opioid medications, importance of opioid destruction, opioid destruction options and medication destruction (Deterra) bag before discharge. Surveys will be sent to group at 6-8 weeks post discharge.
Group II: ControlActive Control1 Intervention
Control group will receive current standard of care education and surveys at 6-8 weeks post discharge.
Find a Location
Who is running the clinical trial?
University of NebraskaLead Sponsor
555 Previous Clinical Trials
1,145,085 Total Patients Enrolled
Kristin R Daniel, PharmDPrincipal InvestigatorUniversity of Nebraska
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am going home with painkillers after knee or hip replacement surgery.I am under 19 years old.I am not prescribed opioids for after I leave the hospital.
Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.